FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127658105> ?p ?o ?g. }

• W2127658105 endingPage "527" @default.
• W2127658105 startingPage "519" @default.
• W2127658105 abstract "Galectin-3 (Gal-3), a member of a family of highly conserved carbohydrate-binding proteins, has recently emerged as a novel cellular modulator at inflammatory foci. Here we investigated the effects of Gal-3 on central effector functions of human neutrophils, including phagocytosis, exocytosis of secretory granules, and survival. We examined the effects of Gal-3 alone or in combination with soluble fibrinogen (sFbg), an extracellular mediator that plays a key role during the early phase of the inflammatory response through binding to integrin receptors. In addition we evaluated the intracellular signals triggered by these mediators in human neutrophils. Human neutrophils incubated with recombinant Gal-3 alone increased their phagocytic activity and CD66 surface expression. In contrast to the known antiapoptotic effect of Gal-3 on many cellular types, Gal-3 enhanced PMN apoptotic rate. Preincubation with Gal-3 primed neutrophils to the effects of sFbg, resulting in a synergistic action on degranulation. On the other hand, Gal-3 and sFbg had opposite effects on PMN survival, and the simultaneous action of both agonists partially counteracted the proapoptotic effects of Gal-3. In addition, although sFbg induced its effects through the activation of the ERKs, Gal-3 led to p38 phosphorylation. Disruption of this signaling pathway abrogated Gal-3-mediated modulation of neutrophil degranulation, phagocytosis, and apoptosis. Together, our results support the notion that Gal-3 and sFbg are two physiological mediators present at inflammatory sites that activate different components of the MAPK pathway and could be acting in concert to modulate the functionality and life span of neutrophils." @default.
• W2127658105 created "2016-06-24" @default.
• W2127658105 creator A5022419643 @default.
• W2127658105 creator A5024226262 @default.
• W2127658105 creator A5026516449 @default.
• W2127658105 creator A5047196610 @default.
• W2127658105 creator A5058854988 @default.
• W2127658105 creator A5073954474 @default.
• W2127658105 creator A5074650623 @default.
• W2127658105 creator A5075511394 @default.
• W2127658105 creator A5081767592 @default.
• W2127658105 date "2004-12-15" @default.
• W2127658105 modified "2023-10-18" @default.
• W2127658105 title "Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways" @default.
• W2127658105 cites W146301169 @default.
• W2127658105 cites W1566737177 @default.
• W2127658105 cites W1593858768 @default.
• W2127658105 cites W1751283081 @default.
• W2127658105 cites W1820344046 @default.
• W2127658105 cites W1938340131 @default.
• W2127658105 cites W1973152090 @default.
• W2127658105 cites W1974089832 @default.
• W2127658105 cites W1977005214 @default.
• W2127658105 cites W1979129905 @default.
• W2127658105 cites W1980333945 @default.
• W2127658105 cites W1982005911 @default.
• W2127658105 cites W1982942596 @default.
• W2127658105 cites W1989710374 @default.
• W2127658105 cites W1999463130 @default.
• W2127658105 cites W2001322216 @default.
• W2127658105 cites W2002475242 @default.
• W2127658105 cites W2005663928 @default.
• W2127658105 cites W2006051699 @default.
• W2127658105 cites W2007986629 @default.
• W2127658105 cites W2013466449 @default.
• W2127658105 cites W2022914311 @default.
• W2127658105 cites W2029231027 @default.
• W2127658105 cites W2032570439 @default.
• W2127658105 cites W2033262206 @default.
• W2127658105 cites W2035936653 @default.
• W2127658105 cites W2037821829 @default.
• W2127658105 cites W2039544710 @default.
• W2127658105 cites W2050736528 @default.
• W2127658105 cites W2053440703 @default.
• W2127658105 cites W2060490044 @default.
• W2127658105 cites W2061460842 @default.
• W2127658105 cites W2061926138 @default.
• W2127658105 cites W2069288734 @default.
• W2127658105 cites W2075104267 @default.
• W2127658105 cites W2093551215 @default.
• W2127658105 cites W2094920104 @default.
• W2127658105 cites W2100115439 @default.
• W2127658105 cites W2103650131 @default.
• W2127658105 cites W2134055095 @default.
• W2127658105 cites W2142168833 @default.
• W2127658105 cites W2142332666 @default.
• W2127658105 cites W2144426613 @default.
• W2127658105 cites W2145408997 @default.
• W2127658105 cites W2147434746 @default.
• W2127658105 cites W2170085660 @default.
• W2127658105 cites W2187627908 @default.
• W2127658105 cites W2235911398 @default.
• W2127658105 cites W312967432 @default.
• W2127658105 cites W4238292561 @default.
• W2127658105 cites W4252859460 @default.
• W2127658105 doi "https://doi.org/10.1093/glycob/cwi026" @default.
• W2127658105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15604089" @default.
• W2127658105 hasPublicationYear "2004" @default.
• W2127658105 type Work @default.
• W2127658105 sameAs 2127658105 @default.
• W2127658105 citedByCount "94" @default.
• W2127658105 countsByYear W21276581052012 @default.
• W2127658105 countsByYear W21276581052013 @default.
• W2127658105 countsByYear W21276581052014 @default.
• W2127658105 countsByYear W21276581052015 @default.
• W2127658105 countsByYear W21276581052016 @default.
• W2127658105 countsByYear W21276581052017 @default.
• W2127658105 countsByYear W21276581052018 @default.
• W2127658105 countsByYear W21276581052019 @default.
• W2127658105 countsByYear W21276581052021 @default.
• W2127658105 countsByYear W21276581052022 @default.
• W2127658105 countsByYear W21276581052023 @default.
• W2127658105 crossrefType "journal-article" @default.
• W2127658105 hasAuthorship W2127658105A5022419643 @default.
• W2127658105 hasAuthorship W2127658105A5024226262 @default.
• W2127658105 hasAuthorship W2127658105A5026516449 @default.
• W2127658105 hasAuthorship W2127658105A5047196610 @default.
• W2127658105 hasAuthorship W2127658105A5058854988 @default.
• W2127658105 hasAuthorship W2127658105A5073954474 @default.
• W2127658105 hasAuthorship W2127658105A5074650623 @default.
• W2127658105 hasAuthorship W2127658105A5075511394 @default.
• W2127658105 hasAuthorship W2127658105A5081767592 @default.
• W2127658105 hasBestOaLocation W21276581052 @default.
• W2127658105 hasConcept C11960822 @default.
• W2127658105 hasConcept C156293190 @default.
• W2127658105 hasConcept C160448771 @default.
• W2127658105 hasConcept C170493617 @default.
• W2127658105 hasConcept C185592680 @default.

• next